Serum GDF-15 has been consistently identified as a predictor of stroke, mortality and bleeding in atrial fibrillation, either alone or included in an ABC (Age, Biomarkers, Clinical history) risk score [5,21]. Here, GDF15 is linked to atrial fibrillation.